Stem cell transplantation shows sustained benefits in severe systemic sclerosis
An international study reports 60% progression-free survival at 10 years after autologous bone marrow transplantation, adding important evidence on sustained positive clinical outcomes and long-term safety in patients treated for early severe systemic sclerosis.
Read original article on The Medical News →Related news
-
Why do we turn to comfort food? A survey of 1,203 adults offers clues
United Kingdom
-
Online reviews reveal troubling side effects of insomnia drug lemborexant
United Kingdom
-
Discarded fruit and vegetable parts offer overlooked fiber benefits
United Kingdom
-
Major studies identify accurate non-invasive tests for liver disease
United Kingdom
-
_-_Illustration_-_Andrii_Vodolazhskyi_M1_4bb73c51d46c449285a21e8af28684d6-620x480.jpg)
Newly discovered protein helps preserve egg chromosome integrity during aging
United Kingdom
-
Multivitamins boost key vitamin levels, but do they improve your health?
United Kingdom
-
Passive tobacco smoke exposure linked to nonallergic atopic dermatitis severity in young children
United Kingdom
-
Brief dietary changes may prime the immune system for inflammation
United Kingdom